← Back to Search

Particle Embolic

Embozene Microspheres for Genital Diseases

N/A
Waitlist Available
Led By Ziv J Haskal, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This study is evaluating whether a new procedure may help reduce symptoms of benign prostatic hyperplasia.

Eligible Conditions
  • Genital Diseases
  • Genitourinary Diseases
  • Prostate Enlargement
  • Benign Prostatic Hyperplasia
  • Enlarged Prostate
  • Overactive Bladder
  • Hyperplasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical improvement in Lower Urinary Tract Symptoms (LUTS)
Presence or absence of ischemic complications to the bladder, rectum, or other pelvic structures
Secondary outcome measures
Post-void residual measured in ml/cc
UCLA-PCI-SF (University of California, Los Angeles Prostate Cancer Index Short Form) score
UCLA-PCI-SF score
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Embozene MicrospheresExperimental Treatment1 Intervention
Embozene Microspheres are spherical particles consisting of a hydrogel core and a poly nanocoat that will be used during study procedure, Prostatic Artery Embolization (PAE) to reduce or eliminate bloodflow to the prostate.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Embozene Microspheres
2014
N/A
~300

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,244,981 Total Patients Enrolled
Siemens Medical SolutionsIndustry Sponsor
23 Previous Clinical Trials
3,578 Total Patients Enrolled
Ziv J Haskal, MDPrincipal InvestigatorProfessor of Radiology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
Ziv Haskal, MD 2015. "Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02592473.
All > Benign Prostatic Hyperplasia > Bph
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top